{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:13:40Z","timestamp":1791170020440,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T00:00:00Z","timestamp":1396915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00345-014-1287-4","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T09:49:14Z","timestamp":1396864154000},"page":"623-630","source":"Crossref","is-referenced-by-count":13,"title":["Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations"],"prefix":"10.1007","volume":"32","author":[{"given":"Timothy","family":"K. Byler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"key":"1287_CR1","unstructured":"Howlader N, Noone AM, Krapcho M et al (2013) SEER cancer statistics review 1975\u20132010. National Cancer Institute, Bethesda, MD. http:\/\/seer.cancer.gov\/statfacts\/html\/kidrp.html . Accessed 24 Sept 2013"},{"issue":"4","key":"1287_CR2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijc.10513","volume":"100","author":"T Gudbjartsson","year":"2002","unstructured":"Gudbjartsson T, Jonasdottir TJ, Thoroddsen A et al (2002) A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas. Int J Cancer 100(4):476\u2013479","journal-title":"Int J Cancer"},{"issue":"84","key":"1287_CR3","first-page":"1","volume":"2","author":"M Sorbellini","year":"2012","unstructured":"Sorbellini M, Bratslavsky G (2012) Decreasing the indications for radical nephrectomy: a study of multifocal renal cell carcinoma. Front Oncol 2(84):1\u20135","journal-title":"Front Oncol"},{"issue":"8","key":"1287_CR4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato Y, Yoshizato T, Shiraishi Y et al (2013) Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 45(8):860\u2013869","journal-title":"Nat Genet"},{"issue":"13","key":"1287_CR5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and risk of death, cardiovascular events, and hospitalization. NEJM 351(13):1296\u20131305","journal-title":"NEJM"},{"key":"1287_CR6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","volume":"7","author":"WC Huang","year":"2006","unstructured":"Huang WC, Levey AS, Serio AM et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735\u2013740","journal-title":"Lancet Oncol"},{"key":"1287_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.juro.2007.08.150","volume":"179","author":"G Bratslavsky","year":"2008","unstructured":"Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL, Linehan WM, Pinto PA (2008) Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol 179:67\u201370","journal-title":"J Urol"},{"key":"1287_CR8","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","volume":"337","author":"HP Neumann","year":"1991","unstructured":"Neumann HP, Wiestler OD (1991) Clustering of features of Von Hippel\u2013Lindau syndrome: evidence for a complex genetic locus. Lancet 337:1052","journal-title":"Lancet"},{"key":"1287_CR9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","volume":"160","author":"HP Neumann","year":"1998","unstructured":"Neumann HP, Bender BU, Berger DP et al (1998) Prevalence, morphology, and biology of renal cell carcinoma in Von Hippel\u2013Lindau disease compared with sporadic renal cell carcinoma. J Urol 160:1248\u20131254","journal-title":"J Urol"},{"key":"1287_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","volume":"12","author":"C Stolle","year":"1998","unstructured":"Stolle C, Glenn GM, Zbar B et al (1998) Improved detection of germline mutations in the Von Hippel\u2013Lindau disease tumor suppressor gene. Hum Mutat 12:417\u2013423","journal-title":"Hum Mutat"},{"key":"1287_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urolonc.2008.11.001","volume":"27","author":"I Rosner","year":"2009","unstructured":"Rosner I, Bratslavsky G, Pinto PA, Linehan WM (2009) The clinical implications of the genetics of renal cell carcinoma. Urol Oncol Semin 27:131\u2013136","journal-title":"Urol Oncol Semin"},{"key":"1287_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/humu.20082","volume":"24","author":"C Gallou","year":"2004","unstructured":"Gallou C, Chauveau D, Richard S et al (2004) Geneotype\u2013phenotype correlations in von Hippel\u2013Lindau disease. Hum Mutat 24:215\u2013224","journal-title":"Hum Mutat"},{"issue":"5","key":"1287_CR13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MOU.0b013e32832f0d40","volume":"19","author":"JA Coleman","year":"2009","unstructured":"Coleman JA, Russo P (2009) Hereditary and familial kidney cancer. Curr Opin Urol 19(5):478\u2013485","journal-title":"Curr Opin Urol"},{"key":"1287_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ki.1997.3","volume":"51","author":"HP Neumann","year":"1997","unstructured":"Neumann HP, Zbar B (1997) Renal cysts, renal cancer, and von Hippel\u2013Lindau disease. Kidney Int 51:16\u201326","journal-title":"Kidney Int"},{"key":"1287_CR15","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) Von Hippel Lindau disease. Lancet 361:2059\u20132067","journal-title":"Lancet"},{"issue":"(3 Pt 1)","key":"1287_CR16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiology.174.3.2305064","volume":"174","author":"PL Choyke","year":"1990","unstructured":"Choyke PL, Filling-Katz MR, Shawker TH et al (1990) Von Hippel\u2013Lindau disease: radiologic screening for visceral manifestations. Radiology 174((3 Pt 1)):815\u2013820","journal-title":"Radiology"},{"key":"1287_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","volume":"172","author":"BG Duffey","year":"2004","unstructured":"Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM (2004) The relationship between renal tumor size and metastases in patients with Von Hippel\u2013Lindau Disease. J Urol 172:63\u201365","journal-title":"J Urol"},{"issue":"1","key":"1287_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.juro.2010.03.035","volume":"184","author":"GN Gupta","year":"2010","unstructured":"Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G (2010) Oncologic outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4\u00a0cm. J Urol 184(1):59\u201363","journal-title":"J Urol"},{"key":"1287_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.juro.2008.03.030","volume":"180","author":"A Johnson","year":"2008","unstructured":"Johnson A, Sudarshan S, Liu J, Linehan WM, Pinto PA, Bratslavsky G (2008) Feasibility and outcomes of repeat partial nephrectomy. J Urol 180:89\u201393","journal-title":"J Urol"},{"issue":"12","key":"1287_CR20","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","volume":"113","author":"AR Birt","year":"1977","unstructured":"Birt AR, Hogg GR, Dube WJ (1977) Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113(12):1674\u20131677","journal-title":"Arch Dermatol"},{"issue":"10","key":"1287_CR21","first-page":"1195","volume":"135","author":"JR Toro","year":"1999","unstructured":"Toro JR, Glenn G, Duray P et al (1999) Birt\u2013Hogg\u2013Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol 135(10):1195\u20131202","journal-title":"Arch Dermatol"},{"key":"1287_CR22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","volume":"76","author":"LS Schmidt","year":"2005","unstructured":"Schmidt LS, Nickerson ML, Warren MB et al (2005) Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt\u2013Hogg\u2013Dube syndrome. Am J Hum Genet 76:1023\u20131033","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1287_CR23","doi-asserted-by":"crossref","first-page":"e15793","DOI":"10.1371\/journal.pone.0015793","volume":"5","author":"S Hong","year":"2010","unstructured":"Hong S, Oh H, Valera VA et al (2010) Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One 5(12):e15793","journal-title":"PLoS One"},{"key":"1287_CR24","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/bjc.2011.463","volume":"105","author":"AC Houweling","year":"2011","unstructured":"Houweling AC, Gijezen LM, Jonker MA et al (2011) Renal cancer and pneumothorax risk in Birt\u2013Hogg\u2013Dube syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Br J Cancer 105:1912\u20131919","journal-title":"Br J Cancer"},{"issue":"12","key":"1287_CR25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","volume":"10","author":"FH Menko","year":"2009","unstructured":"Menko FH, van Steensel MA, Giraud S et al (2009) European BHD Consortium. Birt\u2013Hogg\u2013Dube syndrome: diagnosis and management. Lancet Oncol 10(12):1199\u20131206","journal-title":"Lancet Oncol"},{"issue":"12","key":"1287_CR26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","volume":"26","author":"CP Pavlovich","year":"2002","unstructured":"Pavlovich CP, Walther MM, Eyler RA et al (2002) Renal tumors in the Birt\u2013Hoog\u2013Dube syndrome. Am J Surg Pathol 26(12):1542\u20131552","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1287_CR27","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.juro.2011.02.051","volume":"185","author":"RS Boris","year":"2011","unstructured":"Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011) The impact of germline BHD mutation on histologic concordance and clinical management of patients with bilateral renal masses and known unilateral oncocytoma. J Urol 185(6):2050\u20132055","journal-title":"J Urol"},{"issue":"5","key":"1287_CR28","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","volume":"173","author":"CP Pavlovich","year":"2005","unstructured":"Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS et al (2005) Evaluation and management of renal tumors in the Birt\u2013Hogg\u2013Dube syndrome. J Urol 173(5):1482\u20131486","journal-title":"J Urol"},{"key":"1287_CR29","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","volume":"98","author":"V Launonen","year":"2002","unstructured":"Launonen V, Vierimaa O, Kiuru M et al (2002) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Nat Acad Sci 98:3387\u20133392","journal-title":"Proc Nat Acad Sci"},{"key":"1287_CR30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata, and papillary renal cell cancer. Nat Genet 30:406\u2013410","journal-title":"Nat Genet"},{"key":"1287_CR31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs JS, Jung YJ, Mole DR et al (2005) HIF overexpression correlates with biallelic loss of fumaratehydratase in renal cell cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143\u2013153","journal-title":"Cancer Cell"},{"key":"1287_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","volume":"73","author":"JR Toro","year":"2003","unstructured":"Toro JR, Nickerson ML, Wei MH et al (2003) Mutations in the fumaratehydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95\u2013106","journal-title":"Am J Hum Genet"},{"issue":"10","key":"1287_CR33","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","volume":"31","author":"MJ Merino","year":"2007","unstructured":"Merino MJ, Torres-Cabala C, Pinto P, Linehan WM (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31(10):1578\u20131585","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1287_CR34","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","volume":"177","author":"RL Grubb","year":"2007","unstructured":"Grubb RL, Franks ME, Toro J et al (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177(6):2074\u20132079","journal-title":"J Urol"},{"issue":"3","key":"1287_CR35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","volume":"151","author":"B Zbar","year":"1994","unstructured":"Zbar B, Tory K, Merino M et al (1994) Hereditary papillary renal cell carcinoma. J Urol 151(3):561\u2013566","journal-title":"J Urol"},{"key":"1287_CR36","first-page":"1719","volume":"58","author":"L Schmidt","year":"1998","unstructured":"Schmidt L, Junker K, Weirich G et al (1998) Two North American families with hereditary papillary carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res 58:1719\u20131722","journal-title":"Cancer Res"},{"key":"1287_CR37","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","volume":"170","author":"WM Linehan","year":"2003","unstructured":"Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol 170:2163\u20132172","journal-title":"J Urol"},{"key":"1287_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ucl.2012.01.006","volume":"39","author":"B Shuch","year":"2012","unstructured":"Shuch B, Singer EA, Bratslavsky G (2012) The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. Urol Clin N Am 39:133\u2013148","journal-title":"Urol Clin N Am"},{"key":"1287_CR39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(05)66524-X","volume":"165","author":"JC Herring","year":"2001","unstructured":"Herring JC, Enquist EG, Chernoff A et al (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10\u00a0year experience. J Urol 165:177","journal-title":"J Urol"},{"key":"1287_CR40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","volume":"74","author":"S Vanharanta","year":"2004","unstructured":"Vanharanta S, Buchta M, McWhinney SR et al (2004) Early-onset renal cell carcinoma as a novel ex-traparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 74:153","journal-title":"Am J Hum Genet"},{"key":"1287_CR41","first-page":"1342","volume":"1807","author":"C Bardella","year":"2011","unstructured":"Bardella C, Pollard PJ, Tomlinson I (2011) SDH mutations in cancer. Biochem Biophys Acta 1807:1342\u20131443","journal-title":"Biochem Biophys Acta"},{"key":"1287_CR42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E et al (2010) Tumor risks and genotype\u2013phenotype\u2013proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31:41\u201351","journal-title":"Hum Mutat"},{"key":"1287_CR43","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","volume":"188","author":"CJ Ricketts","year":"2012","unstructured":"Ricketts CJ, Shuch B, Vocke CD et al (2012) Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol 188:2063\u20132071","journal-title":"J Urol"},{"key":"1287_CR44","first-page":"658767","volume":"6","author":"GW Barrisford","year":"2011","unstructured":"Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G (2011) Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol 6:658767","journal-title":"Int J Surg Oncol"},{"key":"1287_CR45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499:43\u201349","journal-title":"Nature"},{"issue":"6","key":"1287_CR46","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.eururo.2006.05.022","volume":"50","author":"M Carini","year":"2006","unstructured":"Carini M, Minervini A, Masieri L, Lapini A, Serni S (2006) Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience. Eur Urol 50(6):1269\u20131271","journal-title":"Eur Urol"},{"issue":"5","key":"1287_CR47","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.juro.2010.12.048","volume":"185","author":"A Minervini","year":"2011","unstructured":"Minervini A, Ficarra V, Rocco F et al (2011) Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol 185(5):1604\u20131610","journal-title":"J Urol"},{"issue":"5","key":"1287_CR48","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.juro.2009.07.064","volume":"182","author":"KJ Kowalczyk","year":"2009","unstructured":"Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G (2009) Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol 182(5):2158\u20132163","journal-title":"J Urol"},{"issue":"3","key":"1287_CR49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/CCO.0b013e32835fc857","volume":"25","author":"EA Singer","year":"2013","unstructured":"Singer EA, Gupta GN, Marchalik D, Srinivasan R (2013) Evolving therapeutic targets in renal cell carcinoma. Curr Opin Oncol 25(3):273\u2013280","journal-title":"Curr Opin Oncol"},{"issue":"10","key":"1287_CR50","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1464-410X.2011.10629.x","volume":"108","author":"C Coppin","year":"2011","unstructured":"Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ (2011) Targeted therapy for advanced renal cell carcinoma (RCC): a Cochrane systemic review of published randomized trials. BJU Int 108(10):1556\u20131563","journal-title":"BJU Int"},{"issue":"3","key":"1287_CR51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/107327481302000310","volume":"20","author":"MN Fishman","year":"2013","unstructured":"Fishman MN (2013) Targeted therapy of kidney cancer: keeping the art around the algorithms. Cancer Control 20(3):222\u2013232","journal-title":"Cancer Control"},{"key":"1287_CR52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.seminoncol.2013.05.002","volume":"40","author":"B Escudier","year":"2013","unstructured":"Escudier B, Gore M (2013) Sequencing therapy in metastatic renal cell cancer. Semin Oncol 40:465\u2013471","journal-title":"Semin Oncol"},{"key":"1287_CR53","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","volume":"22","author":"WM Linehan","year":"2012","unstructured":"Linehan WM (2012) Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res 22:2089\u20132100","journal-title":"Genome Res"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1287-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-014-1287-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1287-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T10:39:30Z","timestamp":1597660770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-014-1287-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1007\/s00345-014-1287-4","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]}}}